Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. (JSPR) Stock Ticker

NASDAQ: JSPR · Healthcare · Biotechnology
$0.6091+4.05%
USD · as of 2026-09-27 · market cap $9.9M
Open JSPR in TickrDownload for iPhone

JSPR right now

46% of the float is sold short.
Options expect by Oct 6±15.1%
Options expect by Oct 29±31.4%
Priced in for Nov 9 earnings±36.7%
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full JSPR picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on JSPR
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.

JSPR stock facts

Ticker symbolJSPR
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market cap$9.9M
CEOJeetinder Singh Mahal
Employees22
HeadquartersRedwood City, CA, US
IPO date2020-01-10
Websitejaspertx.com

What you can see for JSPR on Tickr

Live JSPR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the JSPR report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Jasper Therapeutics, Inc.?

The ticker symbol for Jasper Therapeutics, Inc. is JSPR, listed on the NASDAQ.

What is JSPR?

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and…

HomeExploreMarketLists
All pages